Ready to play
Ready to play
The studies conducted by researchers Emmanuel Mignot and Masashi Yanagisawa have provided a new understanding of the mechanisms of sleep and wakefulness. They discovered the orexin system, which plays a central role in maintaining alertness and combating uncontrolled sleep in narcolepsy. A deficiency in orexin signals leads to severe disruptions in the regulation between sleep and wakefulness, a fact confirmed by research on both animals and humans. It has been found that decreased orexin levels are associated with type 1 narcolepsy. These findings have led to the development of drugs that activate orexin receptors, such as the medication "Orexin Receptor Agonist," which has shown effectiveness in improving wakefulness and reducing episodes of sudden sleep attacks. This medication has been approved for the treatment of the condition, marking a significant breakthrough in the understanding and treatment of sleep disorders.
Notice: This Is an AI-Generated Summary
Comments (0)